Table of Contents Author Guidelines Submit a Manuscript
Journal of Obesity
Volume 2012, Article ID 369097, 6 pages
http://dx.doi.org/10.1155/2012/369097
Review Article

Weight Loss Is Still an Essential Intervention in Obesity and its Complications: A Review

China-Japan Friendship Hospital, Beijing 100029, China

Received 27 February 2012; Accepted 1 May 2012

Academic Editor: Nomelí P. Núñez

Copyright © 2012 Jianzhong Xiao and Wenying Yang. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Fry and W. Finley, “The prevalence and costs of obesity in the EU,” Proceedings of the Nutrition Society, vol. 64, no. 3, pp. 359–362, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Wang, M. A. Beydoun, L. Liang, B. Caballero, and S. K. Kumanyika, “Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic,” Obesity, vol. 16, no. 10, pp. 2323–2330, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. Z. J. Yang, J. Liu, J. P. Ge et al., “Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007-2008 China National Diabetes and Metabolic Disorders Study,” European Heart Journal, vol. 33, no. 2, pp. 213–220, 2012. View at Google Scholar
  4. Y. Matsuzawa, T. Funahashi, and T. Nakamura, “The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism,” Journal of Atherosclerosis and Thrombosis, vol. 18, no. 8, pp. 629–639, 2011. View at Google Scholar
  5. A. C. Frazier-Wood, S. Glasser, W. T. Garvey et al., “A clustering analysis of lipoprotein diameters in the metabolic syndrome,” Lipids in Health and Disease, vol. 19, no. 10, article 237, 2011. View at Google Scholar
  6. M. I. Harris, K. M. Flegal, C. C. Cowie et al., “Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988–1994,” Diabetes Care, vol. 21, no. 4, pp. 518–524, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. K. M. Flegal and R. P. Troiano, “Changes in the distribution of body mass index of adults and children in the US population,” International Journal of Obesity, vol. 24, no. 7, pp. 807–818, 2000. View at Google Scholar · View at Scopus
  8. W. Yang, J. Lu, J. Weng et al., “Prevalence of diabetes among men and women in China,” The New England Journal of Medicine, vol. 362, no. 12, pp. 1090–1101, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. W. B. Kannel, N. Brand, J. J. Skinner, T. R. Dawber, and P. M. McNamara, “The relation of adiposity to blood pressure and development of hypertension. The Framingham study,” Annals of Internal Medicine, vol. 67, no. 1, pp. 48–59, 1967. View at Google Scholar · View at Scopus
  10. R. Stamler, J. Stamler, W. F. Riedlinger et al., “Weight and blood pressure. Findings in hypertension screening of 1 million Americans,” Journal of the American Medical Association, vol. 240, no. 15, pp. 1607–1610, 1978. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Shen, A. Goyal, and L. Sperling, “The emerging epidemic of obesity, diabetes, and the metabolic syndrome in china,” Cardiology Research and Practice, vol. 2012, Article ID 178675, 5 pages, 2012. View at Publisher · View at Google Scholar
  12. M. Badran and I. Laher, “Obesity in arabic-speaking countries,” Journal of Obesity, vol. 2011, Article ID 686430, 9 pages, 2011. View at Publisher · View at Google Scholar
  13. J. E. Manson, W. C. Willett, M. J. Stampfer et al., “Body weight and mortality among women,” The New England Journal of Medicine, vol. 333, no. 11, pp. 677–685, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. S. P. Walker, E. B. Rimm, A. Ascherio, I. Kawachi, M. J. Stampfer, and W. C. Willett, “Body size and fat distribution as predictors of stroke among US men,” American Journal of Epidemiology, vol. 144, no. 12, pp. 1143–1150, 1996. View at Google Scholar · View at Scopus
  15. B. Mokhlesi, “Obesity hypoventilation syndrome: a state-of-the-art review,” Respiratory Care, vol. 55, no. 10, pp. 1347–1362, 2010. View at Google Scholar · View at Scopus
  16. K. M. Maclure, K. C. Hayes, G. A. Colditz, M. J. Stampfer, F. E. Speizer, and W. C. Willett, “Weight, diet, and the risk of symptomatic gallstones in middle-aged women,” The New England Journal of Medicine, vol. 321, no. 9, pp. 563–569, 1989. View at Google Scholar · View at Scopus
  17. L. Hou, X. O. Shu, Y. T. Gao et al., “Anthropometric measurements, physical activity, and the risk of symptomatic gallstone disease in Chinese women,” Annals of Epidemiology, vol. 19, no. 5, pp. 344–350, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. I. R. Wanless and J. S. Lentz, “Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors,” Hepatology, vol. 12, no. 5, pp. 1106–1110, 1990. View at Publisher · View at Google Scholar · View at Scopus
  19. J. M. Schattenberg and D. Schuppan, “Nonalcoholic steatohepatitis: the therapeutic challenge of a global epidemic,” Current Opinion in Lipidology, vol. 22, pp. 479–488, 2011. View at Google Scholar
  20. Z. Yang, X. Wang, J. Wen et al., “Prevalence of non-alcoholic fatty liver disease and its relation to hypoadiponectinaemia in the middle-aged and elderly Chinese population,” Archives of Medical Science, vol. 7, pp. 665–672, 2011. View at Google Scholar
  21. E. E. Calle, C. Rodriguez, K. Walker-Thurmond, and M. J. Thun, “Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults,” The New England Journal of Medicine, vol. 348, no. 17, pp. 1625–1638, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. A. G. Renehan, M. Tyson, M. Egger, R. F. Heller, and M. Zwahlen, “Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies,” The Lancet, vol. 371, no. 9612, pp. 569–578, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. B. F. Riecke, R. Christensen, P. Christensen et al., “Comparing two low-energy diets for the treatment of knee osteoarthritis symptoms in obese patients: a pragmatic randomized clinical trial,” Osteoarthritis and Cartilage, vol. 18, no. 6, pp. 746–754, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Lundgren, C. Bengtsson, G. Blohme, L. Lapidus, and L. Sjostrom, “Adiposity and adipose tissue distribution in relation to incidence of diabetes in women: results from a prospective population study in Gothenburg, Sweden,” International Journal of Obesity, vol. 13, no. 4, pp. 413–423, 1989. View at Google Scholar · View at Scopus
  25. Q. Qiao and R. Nyamdorj, “Is the association of type II diabetes with waist circumference or waist-to-hip ratio stronger than that with body mass index,” European Journal of Clinical Nutrition, vol. 64, no. 1, pp. 30–34, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. Z. Pausova, A. Mahboubi, M. Abrahamowicz et al., “Sex differences in the contributions of visceral and total body fat to blood pressure in adolescence,” Hypertension, vol. 59, pp. 572–579, 2012. View at Google Scholar
  27. F. Toss, P. Wiklund, P. W. Franks et al., “Abdominal and gynoid adiposity and the risk of stroke,” International Journal of Obesity, vol. 35, no. 11, pp. 1427–1432, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. G. M. Reaven, “Role of insulin resistance in human disease,” Diabetes, vol. 37, no. 12, pp. 1595–1607, 1988. View at Google Scholar · View at Scopus
  29. M. Krssak, K. Falk Petersen, A. Dresner et al., “Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study,” Diabetologia, vol. 42, no. 1, pp. 113–116, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. J. B. Meigs, R. B. D'Agostino, P. W. F. Wilson, L. A. Cupples, D. M. Nathan, and D. E. Singer, “Risk variable clustering in the insulin resistance syndrome: the Framingham Offspring Study,” Diabetes, vol. 46, no. 10, pp. 1594–1600, 1997. View at Google Scholar · View at Scopus
  31. S. Purkayastha, G. Zhang, and D. Cai, “Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-β and NF-κB,” Nature Medicine, vol. 17, no. 7, pp. 883–887, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Klein, L. E. Burke, G. A. Bray et al., “Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism,” Circulation, vol. 110, no. 18, pp. 2952–2967, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Oster, D. Thompson, J. Edelsberg, A. P. Bird, and G. A. Colditz, “Lifetime health and economic benefits of weight loss among obese persons,” American Journal of Public Health, vol. 89, no. 10, pp. 1536–1542, 1999. View at Google Scholar · View at Scopus
  34. I. D. Caterson, N. Finer, W. Coutinho et al., “Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial,” Diabetes, Obesity and Metabolism, vol. 14, no. 6, pp. 523–530, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. C. J. Leinum, J. M. Dopp, and B. J. Morgan, “Sleep-disordered breathing and obesity: pathophysiology, complications, and treatment,” Nutrition in Clinical Practice, vol. 24, no. 6, pp. 675–687, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Befort, J. R. Klemp, H. L. Austin et al., “Outcomes of a weight loss intervention among rural breast cancer survivors,” Breast Cancer Research and Treatment, vol. 132, no. 2, pp. 631–639, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Musso, M. Cassader, F. Rosina, and R. Gambino, “Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials,” Diabetologia. In press. View at Publisher · View at Google Scholar · View at Scopus
  38. M. D'Hondt, G. Sergeant, B. Deylgat, D. Devriendt, F. Van Rooy, and F. Vansteenkiste, “Prophylactic cholecystectomy, a mandatory step in morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass?” Journal of Gastrointestinal Surgery, vol. 15, no. 9, pp. 1532–1536, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. D. W. Hay and M. C. Carey, “Pathophysiology and pathogenesis of cholesterol gallstone formation,” Seminars in Liver Disease, vol. 10, no. 3, pp. 159–170, 1990. View at Google Scholar · View at Scopus
  40. D. Festi, A. Colecchia, M. Orsini et al., “Gallbladder motility and gallstone formation in obese patients following very low calorie diets. Use it (fat) to lose it (well),” International Journal of Obesity, vol. 22, no. 6, pp. 592–600, 1998. View at Google Scholar · View at Scopus
  41. K. Miller, E. Hell, B. Lang, and E. Lengauer, “Gallstone formation prophylaxis after gastric restrictive procedures for weight loss: a randomized double-blind placebo-controlled trial,” Annals of Surgery, vol. 238, no. 5, pp. 697–702, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. R. A. Carels, K. M. Young, C. Coit, A. M. Clayton, A. Spencer, and M. Hobbs, “Can following the caloric restriction recommendations from the Dietary Guidelines for Americans help individuals lose weight?” Eating Behaviors, vol. 9, no. 3, pp. 328–335, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. G. Boden, K. Sargrad, C. Homko, M. Mozzoli, and T. P. Stein, “Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes,” Annals of Internal Medicine, vol. 142, no. 6, pp. 403–411, 2005. View at Google Scholar · View at Scopus
  44. P. Stiegler and A. Cunliffe, “The role of diet and exercise for the maintenance of fat-free mass and resting metabolic rate during weight loss,” Sports Medicine, vol. 36, no. 3, pp. 239–262, 2006. View at Google Scholar · View at Scopus
  45. D. A. Schoeller, K. Shay, and R. F. Kushner, “How much physical activity is needed to minimize weight gain in previously obese women?” American Journal of Clinical Nutrition, vol. 66, no. 3, pp. 551–556, 1997. View at Google Scholar · View at Scopus
  46. J. M. Jakicic, B. H. Marcus, K. I. Gallagher, M. Napolitano, and W. Lang, “Effect of exercise duration and intensity on weight loss in overweight, sedentary women: a randomized trial,” Journal of the American Medical Association, vol. 290, no. 10, pp. 1323–1330, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. T. A. Wadden, S. Volger, D. B. Sarwer et al., “A two-year randomized trial of obesity treatment in primary care practice,” The New England Journal of Medicine, vol. 365, no. 21, pp. 1969–1979, 2011. View at Google Scholar
  48. A. Avenell, J. Broom, T. J. Brown et al., “Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement,” Health Technology Assessment, vol. 8, no. 21, pp. 1–182, 2004. View at Google Scholar · View at Scopus
  49. R. Padwal, S. K. Li, and D. C. Lau, “Long-term pharmacotherapy for obesity and overweight,” Cochrane Database of Systematic Reviews (Online), no. 3, article CD004094, 2004. View at Google Scholar · View at Scopus
  50. T. A. Wadden, R. I. Berkowitz, L. G. Womble et al., “Randomized trial of lifestyle modification and pharmacotherapy for obesity,” The New England Journal of Medicine, vol. 353, no. 20, pp. 2111–2120, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. M. A. Khan, C. A. Herzog, J. V. S. Peter et al., “The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite- suppressant drugs,” The New England Journal of Medicine, vol. 339, no. 11, pp. 713–718, 1998. View at Publisher · View at Google Scholar · View at Scopus
  52. W. N. Kernan, C. M. Viscoli, L. M. Brass et al., “Phenylpropanolamine and the risk of hemorrhagic stroke,” The New England Journal of Medicine, vol. 343, no. 25, pp. 1826–1832, 2000. View at Publisher · View at Google Scholar · View at Scopus
  53. W. T. Garvey, D. H. Ryan, M. Look et al., “Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study,” American Journal of Clinical Nutrition, vol. 95, no. 2, pp. 297–308, 2012. View at Google Scholar
  54. J. Zhi, A. T. Melia, C. Funk et al., “Metabolic profiles of minimally absorbed orlistat in obese/overweight volunteers,” Journal of Clinical Pharmacology, vol. 36, no. 11, pp. 1006–1011, 1996. View at Google Scholar · View at Scopus
  55. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm179166.htm.
  56. F. Folli and R. Guardado Mendoza, “Potential use of exenatide for the treatment of obesity,” Expert Opinion on Investigational Drugs, vol. 20, pp. 1717–1722, 2011. View at Google Scholar
  57. Y. Zhang and C. Huang, “Targeting adipocyte apoptosis: a novel strategy for obesity therapy,” Biochemical and Biophysical Research Communications, vol. 417, no. 1, pp. 1–4, 2012. View at Google Scholar
  58. L. Sjöström, M. Peltonen, P. Jacobson et al., “Bariatric surgery and long-term cardiovascular events,” JAMA: The Journal of the American Medical Association, vol. 307, no. 1, pp. 56–65, 2012. View at Google Scholar
  59. B. M. Wolfe and J. M. Morton, “Weighing in on bariatric surgery: procedure use, readmission rates, and mortality,” Journal of the American Medical Association, vol. 294, no. 15, pp. 1960–1963, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. P. Marceau, F. S. Hould, S. Simard et al., “Biliopancreatic diversion with duodenal switch,” World Journal of Surgery, vol. 22, no. 9, pp. 947–954, 1998. View at Publisher · View at Google Scholar · View at Scopus
  61. W. J. Pories, M. S. Swanson, K. G. MacDonald et al., “Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus,” Annals of Surgery, vol. 222, no. 3, pp. 339–352, 1995. View at Google Scholar · View at Scopus
  62. L. D. MacLean, B. M. Rhode, J. Sampalis et al., “Results of the surgical treatment of obesity,” American Journal of Surgery, vol. 165, no. 1, pp. 155–162, 1993. View at Google Scholar · View at Scopus
  63. H. J. Sugerman, J. M. Kellum, K. M. Engle et al., “Gastric bypass for treating severe obesity,” American Journal of Clinical Nutrition, vol. 55, no. 2, pp. 560S–566S, 1992. View at Google Scholar · View at Scopus
  64. “Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement,” American Journal of Clinical Nutrition, vol. 55, no. 2, supplement, pp. 615S–619S, 1992. View at Scopus
  65. J. B. Dixon, P. Zimmet, K. G. Alberti, and F. Rubino, “Bariatric surgery: an IDF statement for obese Type 2 diabetes em obesos,” Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 55, no. 6, pp. 367–382, 2011. View at Publisher · View at Google Scholar · View at Scopus